American Society of Human Genetics: Researchers Quantify Limitations of Health Reports From Direct-to-Consumer Genetic Tests
October 17, 2019
October 17, 2019
HOUSTON, Texas, Oct. 17 -- The American Society of Human Genetics issued the following news release:
Health reports from direct-to-consumer (DTC) genetic tests that use a limited variant screening approach often yield clinical false-negative results, which pose the risk of informing health care decisions based on incomplete information, according to findings presented at the American Society of Human Genetics (ASHG) 2019 Annual Meeting in Houston, Texas.
Limited variant . . .
Health reports from direct-to-consumer (DTC) genetic tests that use a limited variant screening approach often yield clinical false-negative results, which pose the risk of informing health care decisions based on incomplete information, according to findings presented at the American Society of Human Genetics (ASHG) 2019 Annual Meeting in Houston, Texas.
Limited variant . . .